EP
Eledon Pharmaceuticals Inc
🇺🇸XNAS.ELDNUnited StatesHealthcare
$2.70USDdown -0.01 (-0.37%)OpenDelayed5:45 PM
Price$2.70-0.01 (-0.37%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US28617K1016
- CUSIP
- 28617K101
Company
- Employees
- 33
- Headquarters
- Irvine, United States
- Website
- https://eledon.com
- CEO
- Dr. David-Alexandre C. Gros M.D., Ph.D.
Market
- Shares outstanding
- 81.3M
- Market cap
- $219.41M
Highlights
- Market cap
- $220.22M
- EPS LTM
- -$0.87
- P/E LTM
- -4.46
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$98.56M-773.09%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$73.86M-14.46%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.